Knockdown and overexpression experiments in human colon cancer cells implicated an apparent oncogenic role for ACE2, with pharmacologic BET inhibition recapitulating molecular and phenotypic readouts, including loss of c-Myc, cell growth inhibition, and apoptosis induction. Here, DNER is linked to malignant colon neoplasm.